Why Do Pathological Stage IA Lung Adenocarcinomas Vary From Prognosis?: A Clinicopathologic Study of 176 Patients With Pathological Stage IA Lung Adenocarcinoma Based on the IASLC/ATS/ERS Classification

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31829f09a7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.09-26 Clinical Significance of Subcellular Localization of Maspin in Patients With Pathological Stage IA Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.09-27 Prognostic Significance of Vascular Invasion in Pathological Stage IA Lung Adenocarcinoma According to the 8th Edition of the TNM Classification

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.16-49 Which Nomogram Is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.16-25 Impact of Diabetes Mellitus on Survival Outcome in Patients With Pathological Stage IA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Distinct Clinicopathological Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical-Stage IA Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P2.16-30 Surgical Strategy for Clinical Stage IA Non-Small Cell Lung Cancer Patients With Risk Factors of Pathological Invasion and/or Metastasis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of Clinical/Pathological Stage IA Non-Small-Cell Lung Cancer Showing Partially Solid or Solid Tumours on Radiological Exam

Annals of Thoracic and Cardiovascular Surgery
GastroenterologyCardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2015English

P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit From Adjuvant Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer With IA Stage: A Population-Based Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy